Mechanism of HSV infection through soluble adapter-mediated virus bridging to the EGF receptor

Virology

Volumn 413, Issue 1, 2011, Pages 12-18

  Nakano, Kenji ^a   Kobayashi, Masatoshi ^b   Nakamura, Kei Ichiro ^b   Nakanishi, Takeshi ^c   Asano, Ryutaro ^c   Kumagai, Izumi ^c   Tahara, Hideaki ^d   Kuwano, Michihiko ^a   Cohen, Justus B ^e   Glorioso, Joseph C ^e  

^a KYUSHU UNIVERSITY   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Bispecific adapter; EGF receptor; Endocytosis; Fusion; HSV entry

Indexed keywords

ADAPTOR PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCOPROTEIN D;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOSOME; FEMALE; HERPES SIMPLEX VIRUS; IN VIVO STUDY; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; VIRUS CAPSID; VIRUS ENTRY; VIRUS INFECTION;

ANIMALS; CELL LINE; CRICETINAE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; PROTEIN BINDING; RECEPTOR, EPIDERMAL GROWTH FACTOR; SINGLE-CHAIN ANTIBODIES; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

MIRIDAE; SIMPLEXVIRUS;

EID: 79953072979     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.02.014     Document Type: Article

References (30)

1. Anliker B., Abel T., Kneissl S., Hlavaty J., Caputi A., Brynza J., Schneider I.C., Munch R.C., Petznek H., Kontermann R.E., Koehl U., Johnston I.C., Keinanen K., Muller U.C., Hohenadl C., Monyer H., Cichutek K., Buchholz C.J. Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors. Nat. Methods 2010, 7(11):929-935.
2. Baek H., Uchida H., Jun K., Kim J.H., Kuroki M., Cohen J.B., Glorioso J.C., Kwon H. Bispecific adapter-mediated retargeting of a receptor-restricted HSV-1 vector to CEA-bearing tumor cells. Mol. Ther. 2011, 19(3):507-514.
3. Campadelli-Fiume G., Amasio M., Avitabile E., Cerretani A., Forghieri C., Gianni T., Menotti L. The multipartite system that mediates entry of herpes simplex virus into the cell. Rev. Med. Virol. 2007, 17(5):313-326.
4. Chen X., Li J., Mata M., Goss J., Wolfe D., Glorioso J.C., Fink D.J. Herpes simplex virus type 1 ICP0 protein does not accumulate in the nucleus of primary neurons in culture. J. Virol. 2000, 74(21):10132-10141.
5. Clement C., Tiwari V., Scanlan P.M., Valyi-Nagy T., Yue B.Y., Shukla D. A novel role for phagocytosis-like uptake in herpes simplex virus entry. J. Cell Biol. 2006, 174(7):1009-1021.
6. Craft A.M., Krisky D.M., Wechuck J.B., Lobenhofer E.K., Jiang Y., Wolfe D.P., Glorioso J.C. Herpes simplex virus-mediated expression of Pax3 and MyoD in embryoid bodies results in lineage-related alterations in gene expression profiles. Stem Cells 2008, 26(12):3119-3129.
7. Gianni T., Campadelli-Fiume G., Menotti L. Entry of herpes simplex virus mediated by chimeric forms of nectin1 retargeted to endosomes or to lipid rafts occurs through acidic endosomes. J. Virol. 2004, 78(22):12268-12276.
8. Gill G.N., Kawamoto T., Cochet C., Le A., Sato J.D., Masui H., McLeod C., Mendelsohn J. Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity. J. Biol. Chem. 1984, 259(12):7755-7760.
9. Ishikawa F., Shimazu H., Shultz L.D., Fukata M., Nakamura R., Lyons B., Shimoda K., Shimoda S., Kanemaru T., Nakamura K., Ito H., Kaji Y., Perry A.C., Harada M. Purified human hematopoietic stem cells contribute to the generation of cardiomyocytes through cell fusion. FASEB J. 2006, 20(7):950-952.
10. Krisky D.M., Marconi P.C., Oligino T., Rouse R.J., Fink D.J., Glorioso J.C. Rapid method for construction of recombinant HSV gene transfer vectors. Gene Ther. 1997, 4(10):1120-1125.
11. Krisky D.M., Wolfe D., Goins W.F., Marconi P.C., Ramakrishnan R., Mata M., Rouse R.J., Fink D.J., Glorioso J.C. Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Ther. 1998, 5(12):1593-1603.
12. Kwon H., Bai Q., Baek H.J., Felmet K., Burton E.A., Goins W.F., Cohen J.B., Glorioso J.C. Soluble V domain of Nectin-1/HveC enables entry of herpes simplex virus type 1 (HSV-1) into HSV-resistant cells by binding to viral glycoprotein D. J. Virol. 2006, 80(1):138-148.
13. Menotti L., Nicoletti G., Gatta V., Croci S., Landuzzi L., De Giovanni C., Nanni P., Lollini P.L., Campadelli-Fiume G. Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells. Proc. Natl Acad. Sci. USA 2009, 106(22):9039-9044.
14. Mercer J., Helenius A. Virus entry by macropinocytosis. Nat. Cell Biol. 2009, 11(5):510-520.
15. Milne R.S., Nicola A.V., Whitbeck J.C., Eisenberg R.J., Cohen G.H. Glycoprotein D receptor-dependent, low-pH-independent endocytic entry of herpes simplex virus type 1. J. Virol. 2005, 79(11):6655-6663.
16. Nakano K., Asano R., Tsumoto K., Kwon H., Goins W.F., Kumagai I., Cohen J.B., Glorioso J.C. Herpes simplex virus targeting to the EGF receptor by a gD-specific soluble bridging molecule. Mol. Ther. 2005, 11(4):617-626.
17. Nicola A.V., Straus S.E. Cellular and viral requirements for rapid endocytic entry of herpes simplex virus. J. Virol. 2004, 78(14):7508-7517.
18. Nicola A.V., McEvoy A.M., Straus S.E. Roles for endocytosis and low pH in herpes simplex virus entry into HeLa and Chinese hamster ovary cells. J. Virol. 2003, 77(9):5324-5332.
19. Nicola A.V., Hou J., Major E.O., Straus S.E. Herpes simplex virus type 1 enters human epidermal keratinocytes, but not neurons, via a pH-dependent endocytic pathway. J. Virol. 2005, 79(12):7609-7616.
20. Puskovic V., Wolfe D., Goss J., Huang S., Mata M., Glorioso J.C., Fink D.J. Prolonged biologically active transgene expression driven by HSV LAP2 in brain in vivo. Mol. Ther. 2004, 10(1):67-75.
21. Reilly R.M., Gariepy J. Factors influencing the sensitivity of tumor imaging with a receptor-binding radiopharmaceutical. J. Nucl. Med. 1998, 39(6):1036-1043.
22. Sorkin A., Goh L.K. Endocytosis and intracellular trafficking of ErbBs. Exp. Cell Res. 2008, 314(17):3093-3106.
23. Spear P.G. Entry of alphaherpesviruses into cells. Sem. Virol. 1993, 4:167-180.
24. Spear P.G. Herpes simplex virus: receptors and ligands for cell entry. Cell. Microbiol. 2004, 6(5):401-410.
25. Spear P.G., Eisenberg R.J., Cohen G.H. Three classes of cell surface receptors for alphaherpesvirus entry. Virology 2000, 275(1):1-8.
26. Uchida H., Shah W.A., Ozuer A., Frampton A.R., Goins W.F., Grandi P., Cohen J.B., Glorioso J.C. Generation of herpesvirus entry mediator (HVEM)-restricted herpes simplex virus type 1 mutant viruses: resistance of HVEM-expressing cells and identification of mutations that rescue nectin-1 recognition. J. Virol. 2009, 83(7):2951-2961.
27. van Beusechem V.W., Mastenbroek D.C., van den Doel P.B., Lamfers M.L., Grill J., Wurdinger T., Haisma H.J., Pinedo H.M., Gerritsen W.R. Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors. Gene Ther. 2003, 10(23):1982-1991.
28. Verheije M.H., Wurdinger T., van Beusechem V.W., de Haan C.A., Gerritsen W.R., Rottier P.J. Redirecting coronavirus to a nonnative receptor through a virus-encoded targeting adapter. J. Virol. 2006, 80(3):1250-1260.
29. Wu N., Watkins S.C., Schaffer P.A., DeLuca N.A. Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22. J. Virol. 1996, 70:6358-6368.
30. Zhou G., Roizman B. Construction and properties of a herpes simplex virus 1 designed to enter cells solely via the IL-13alpha2 receptor. Proc. Natl Acad. Sci. USA 2006, 103(14):5508-5513.